OPCH logo

OPTION CARE HEALTH INC

OPCHNASDAQ
πŸ† #1285 by market capEarnings Oct 28US Equity
$24.08β–Ό $0.41 (βˆ’1.71%)
πŸŒ™ After hours$24.08β–² 0.00%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 1.7%
7dβ–² 1.6%
14dβ–² 0.7%
30dβ–² 11.0%
1yβ–Ό 15.6%
🏦Market Cap
$3.61B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+6.0%
Slowing
πŸ“ŠGross Margin
19.1%
Thin
πŸ’΅FCF Margin
5.7%
Moderate
βš–οΈP/S Ratio
0.6x
Cheap
Otter Score
51
Weak

Trading Snapshot

Day Range
$23.85 – $24.23
52-Week Range
$18.01 – $36.80
Volume
$3.56B
Avg Volume
$2.61B
Shares Outstanding
149.8M
Next Earnings
Oct 3, 2026

Fundamentals Snapshot

Annual Revenue
$5.65B
Last Q Revenue
$1.44B
P/E Ratio
17.4
P/S Ratio
0.6x
EPS (TTM)
$1.32
Dividend Yield
β€”

Why Investors Own OPCH

  • βœ“High-growth profile β€” revenue up +10.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 52% gross margin and 29% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$5.65Bβ–² +8.5% YoY
Gross Margin (TTM)
52.2%β–² +0.1% YoY
Operating Income (TTM)
$893Mβ–² +8.5% YoY
Free Cash Flow (TTM)
$1.64Bβ–² +8.5% YoY

About OPTION CARE HEALTH INC

Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
51/100

Analyst Price Target

β“˜
Average Target
$25.56
β–² +6.1% Upside
High Target$27.81
Low Target$19.87
Based on 19 analysts

Latest News & Updates